Retrospective Evaluation of Toxoplasma gondii Serological Test Results of Trakya University Health Center for Medical Research and Practice
PDF
Cite
Share
Request
Original Investigation
P: 6-10
March 2023

Retrospective Evaluation of Toxoplasma gondii Serological Test Results of Trakya University Health Center for Medical Research and Practice

Turkiye Parazitol Derg 2023;47(1):6-10
1. Trakya Üniversitesi Tıp Fakültesi, Tıbbi Mikrobiyoloji Anabilim Dalı, Edirne, Türkiye
No information available.
No information available
Received Date: 14.10.2022
Accepted Date: 26.12.2022
Publish Date: 02.03.2023
PDF
Cite
Share
Request

ABSTRACT

Objective:

Toxoplasma gondii (T. gondii) is an obligate intracellular parasite distributed worldwide. Serological tests investigating antibodies specific to T. gondii are widely used in diagnosis. The aim of this study was to evaluate the results of anti-T. gondii IgG, anti-T. gondii IgM, and anti-T. gondii IgG avidity tests, which were sent to the Serology Laboratory of Trakya University Health Center for Medical Research and Practice, retrospectively.

Methods:

Anti-T. gondii IgM, anti-T. gondii IgG, and anti-T. gondii IgG avidity tests were studied by enzyme-linked fluorescent assay or electrochemiluminescence immunoassay method between January 2012 and December 2021. The test results were evaluated retrospectively from laboratory records.

Results:

Of 18,659 serum samples were studied for anti-T. gondii IgG, 5,127 (27.5%) samples were positive, whereas 721 (3.4%) of 21,108 samples were positive for anti-T. gondii IgM. Of the 593 serum samples tested for IgG avidity, 206 (34.7%) samples had low avidity, 118 (19.9%) had borderline, and 269 (45.4%) had high avidity.

Conclusion:

Our study, compatible with other studies, showed that seropositivity is high in our region, which is not negligible. Especially in women of reproductive age population, T. gondii should be considered in suspected clinical cases.

Keywords: Toxoplasma gondii, seroprevalence, Thrace, Turkey

References

1
Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004; 363: 1965-76.
2
Robert-Gangneux F, Dardé ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev 2012; 25: 264-96.
3
Dubey J, Jones J. Toxoplasma gondii infection in humans and animals in the United States. Int J Parasitol 2008; 38: 1257-78.
4
El Hajj RE, Tawk L, Itani S, Hamie M, Ezzeddine J, El Sabban M, et al. Toxoplasmosis: Current and emerging parasite druggable targets. Microorganisms 2021; 9: 2531.
5
Khan K, Khan W. Congenital toxoplasmosis: An overview of the neurological and ocular manifestations. Parasitol Int 2018; 67: 715-21.
6
Saadatnia G, Golkar M. A review on human toxoplasmosis. Scand J Infect Dis 2012; 44: 805-14.
7
Montoya JG, Liesenfeld O, Kinney S, Press C, Remington JS. VIDAS test for avidity of Toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women. J Clin Microbiol 2002; 40: 2504-8.
8
Ybañez RHD, Ybañez AP, Nishikawa Y. Review on the current trends of toxoplasmosis serodiagnosis in humans. Front Cell Infect Microbiol 2020; 10: 204.
9
Borkakoty B, Biswas D, Jakharia A, Mahanta J. Seroprevalence of Toxoplasma gondii among pregnant women in Northeast India. J Assoc Physicians India 2016; 64: 24-8.
10
Pinto-Ferreira F, Caldart ET, Pasquali AKS, Mitsuka-Bregano R, Freire RL, Navarro IT. Patterns of transmission and sources of infection in outbreaks of human toxoplasmosis. Emerg Infect Dis 2019; 25: 2177-82.
11
EFSA and ECDC (European Food Safety Authority and European Centre forDisease Prevention and Control). The European Union One Health 2020 Zoonoses Report. EFSA Journal 2021; 19: 6971.
12
Malatyalı E, Yıldız İ, Tileklioğlu E, Ertabaklar H, Ertuğ S. Adnan Menderes Üniversitesi Tıp Fakültesi Parazitoloji Laboratuvarı 2007-2017 yılları arası Toxoplasma gondii seroloji sonuçlarının retrospektif olarak değerlendirilmesi. Turkiye Parazitol Derg 2019; 43: 1-4.
13
Centers for Disease Control and Prevention. Parasites - Toxoplasmosis (Toxoplasma infection).  Available from URL: https://www.cdc.gov/parasites/toxoplasmosis/epi.html Accessed: September 28, 2022
14
Xiao Y, Yin J, Jiang N, Xiang M, Hao L, Lu H, et al. Seroepidemiology of human Toxoplasma gondii infection in China. BMC Infect Dis 2010; 10: 4.
15
Wilking H, Thamm M, Stark K, Aebischer T, Seeber F. Prevalence, incidence estimations, and risk factors of Toxoplasma gondii infection in Germany: a representative, cross-sectional, serological study. Sci Rep 2016; 6: 22551.
16
Tekay F, Özbek E. Çiğ köftenin yaygın tüketildiği Şanlıurfa ilinde kadınlarda Toxoplasma gondii seroprevalansı. Turkiye Parazitol Derg 2007; 31: 176-9.
17
Maçin S, Fındık D, Demircan A, Arslan U, Türk Dağı H. Evaluation of Toxoplasma gondii seropositivity and the results of IgG avidity test of patients with suspected Toxoplasmosis. CMJ 2018; 40: 203-7.
18
Alver O, Göral G, Ercan İ. Investigation of serological results of patients with suspected toxoplasmosis admitted to the elısa laboratory of Uludağ University Hospital between 2002-2008. Turkiye Parazitol Derg 2014; 38: 141-6.
19
Aydın Türkoğlu Ş, Karabörk Ş, Çakmak M, Orallar H, Yaman K, Ayaz E. Investigation of a 6-year seropositivity of Toxoplasma gondii in Abant Izzet Baysal University Educational Research Hospital. Turkiye Parazitol Derg 2018; 42: 106-12.
20
Esenkaya Taşbent F, Beder D, Özdemir M, Doğan M, Feyzioğlu B. Hastanemizdeki farkli hasta gruplarinda Toxoplasma gondii seroprevalansı. Turkiye Parazitol Derg 2022; 46: 1-6.
21
Ünal G, Çiçek C, Aksoy MD, Şakru N. Trakya Üniversitesi Tıp Fakültesi Hastanesi Mikrobiyoloji Laboratuvarına gelen Toxoplasma gondii şüpheli olguların retrospektif olarak değerlendirilmesi. 17. Ulusal Parazitoloji Kongresi ve Kafkasya ve Ortadoğu Paraziter Hastalıklar Sempozyumu Program ve Özet Kitabı. 4-10 Eylül 2011 Kars, Türkiye.
22
Yener C, Varol F, Uzun I, Sütcü H, Yeşildağ B, Başar B, et al. Seroprevalence of Toxoplasma gondii antibodies in pregnant women in Thrace region of Turkey - A tertiary center experience. Haydarpasa Numune Med J 2021; 61: 445-50.
23
Selek MB, Bektöre B, Baylan O, Özyurt M. Serological Investigation of Toxoplasma gondii on Pregnant Women and Toxoplasmosis Suspected Patients Between 2012-2014 Years on a Tertiary Training Hospital. Turkiye Parazitol Derg 2015; 39: 200-4.
24
Şirin MC, Cezaroğlu Y, Cicioğlu Arıdoğan B, Sesli Çetin E. Evaluation of Toxoplasma gondii Seroprevalence İn Different Age Groups And IgG Avidity Test Results in Isparta province. Med J SDU 2020; 27: 226-33.
25
Sensini A. Toxoplasma gondii infection in pregnancy: opportunities and pitfalls of serological diagnosis. Clin Microbiol Infect 2006; 12: 504-12.
26
Pekintürk N, Çekin Y, Gür N. Antalya ilinde bir mikrobiyoloji laboratuvarına Toxoplasma gondii antikorları araştırılması amacıyla başvuran doğurganlık yaş grubu kadın olgulara ait sonuçların retrospektif olarak değerlendirilmesi. Turkiye Parazitol Derg 2012; 36: 96-9.
27
Aynali A, Cicioğlu Arıdoğan B, Tola EN, Önal S, Sesli Çetin E. Süleyman Demirel Üniversitesi Tıp Fakültesi Hastanesi'ne başvuran doğurganlık çağındaki kadınlarda gözlenen anti-Toxoplasma IgM-IgG seropozitifliği. Turk Hij Den Biyol Derg 2016; 73: 33-8.
28
Remington JS, Thulliez P, Montoya JG. Recent developments for diagnosis of toxoplasmosis. J Clin Microbiol 2004; 42: 941-5.
29
Bahar İH, Karaman M, Kırdar S, Yılmaz Ö, Celiloğlu M, Mutlu D. Gebelikte toxoplasmosis tanısında anti-Toxoplasma gondii IgM, IgG, IgA antikor ve IgG avidite testlerinin birlikteliği ve önemi. Turkiye Parazitol Derg 2005; 29: 76-9.
30
Yazısız H, Öngüt G, Öztürk Eryiğit F, Özhak B, Öğünç D, Sağlık İ, et al. Akdeniz Üniversitesi Hastanesi Laboratuvarı'nda anti-Toxoplasma gondii IgG, IgM ve IgG avidite sonuçlarının retrospektif olarak değerlendirilmesi. Türk Mikrobiyoloji Cem Derg 2019; 49: 92-7.
2024 ©️ Galenos Publishing House